TNF and trigeminal nerve disorder: The oral administration of DMC (100 and 200 mg/kg; p.o. for 10 consecutive days) attenuates the TNF-α-induced trigeminal neuralgia in a dose and time-dependent manner when compared to the TNF-α-administered group.